Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth R Carson

Showing results (51-60 of 92) with videos related to

Pageof 10
Sort By:
Clinical Genitourinary Cancer|July 26, 2023
Hospitalizations Among Veterans Treated for Metastatic Prostate Cancer With Abiraterone or EnzalutamideForest Riekhof, Yan Yan, Charles L Bennett, et al.
Prostate Cancer and Prostatic Diseases|September 14, 2022
Survival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseasesMartin W Schoen, Kenneth R Carson, Seth A Eisen, et al.
Prostate Cancer and Prostatic Diseases|May 30, 2023
Correction to: Survival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseasesMartin W Schoen, Kenneth R Carson, Seth A Eisen, et al.
Journal of the National Cancer Institute|July 7, 2016
Longitudinal Body Composition Changes in Diffuse Large B-cell Lymphoma Survivors: A Retrospective Cohort Study of United States VeteransDaphne Y Xiao, Suhong Luo, Katiuscia O'Brian, et al.
The Oncologist|September 20, 2013
Influence of body mass index on survival in veterans with multiple myelomaTracey S Beason, Su-Hsin Chang, Kristen M Sanfilippo, et al.
Hematology. American Society of Hematology. Education Program|December 10, 2013
The ASH Choosing Wisely®campaign: five hematologic tests and treatments to questionLisa K Hicks, Harriet Bering, Kenneth R Carson, et al.
Blood|December 6, 2013
The ASH Choosing Wisely® campaign: five hematologic tests and treatments to questionLisa K Hicks, Harriet Bering, Kenneth R Carson, et al.
JAMA Network Open|February 7, 2025
Cumulative Excess Body Mass Index and MGUS Progression to MyelomaLawrence Liu, Nikhil Grandhi, Mei Wang, et al.
American Journal of Hematology|August 6, 2019
Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE scoreKristen M Sanfilippo, Suhong Luo, Tzu-Fei Wang, et al.
American Journal of Hematology|May 7, 2016
Identifying existing Choosing Wisely recommendations of high relevance and importance to hematologyLisa K Hicks, Anita Rajasekhar, Harriet Bering, et al.
Pageof 10

Showing results (51-60 of 92) with videos related to

Sort By:
Pageof 10
Clinical Genitourinary Cancer|July 26, 2023
Hospitalizations Among Veterans Treated for Metastatic Prostate Cancer With Abiraterone or EnzalutamideForest Riekhof, Yan Yan, Charles L Bennett, et al.
Prostate Cancer and Prostatic Diseases|September 14, 2022
Survival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseasesMartin W Schoen, Kenneth R Carson, Seth A Eisen, et al.
Prostate Cancer and Prostatic Diseases|May 30, 2023
Correction to: Survival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseasesMartin W Schoen, Kenneth R Carson, Seth A Eisen, et al.
Journal of the National Cancer Institute|July 7, 2016
Longitudinal Body Composition Changes in Diffuse Large B-cell Lymphoma Survivors: A Retrospective Cohort Study of United States VeteransDaphne Y Xiao, Suhong Luo, Katiuscia O'Brian, et al.
The Oncologist|September 20, 2013
Influence of body mass index on survival in veterans with multiple myelomaTracey S Beason, Su-Hsin Chang, Kristen M Sanfilippo, et al.
Hematology. American Society of Hematology. Education Program|December 10, 2013
The ASH Choosing Wisely®campaign: five hematologic tests and treatments to questionLisa K Hicks, Harriet Bering, Kenneth R Carson, et al.
Blood|December 6, 2013
The ASH Choosing Wisely® campaign: five hematologic tests and treatments to questionLisa K Hicks, Harriet Bering, Kenneth R Carson, et al.
JAMA Network Open|February 7, 2025
Cumulative Excess Body Mass Index and MGUS Progression to MyelomaLawrence Liu, Nikhil Grandhi, Mei Wang, et al.
American Journal of Hematology|August 6, 2019
Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE scoreKristen M Sanfilippo, Suhong Luo, Tzu-Fei Wang, et al.
American Journal of Hematology|May 7, 2016
Identifying existing Choosing Wisely recommendations of high relevance and importance to hematologyLisa K Hicks, Anita Rajasekhar, Harriet Bering, et al.
Pageof 10